{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:03:39Z","timestamp":1787907819798,"version":"build-2784847793"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008591","name":"Fondazione Grigioni per Il Morbo di Parkinson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008591","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.parkreldis.2024.106983","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T03:42:58Z","timestamp":1715139778000},"page":"106983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Mucuna pruriens to treat Parkinson's disease in low-income countries: Recommendations and practical guidelines from the farmer to clinical trials. Paving the way for future use in clinical practice"],"prefix":"10.1016","volume":"124","author":[{"given":"Serena","family":"Caronni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Del Sorbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Barichella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Fothergill-Misbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Denne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janeth","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Urasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke C.J.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Akpalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred Stephen","family":"Sarfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momodou","family":"Cham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Pezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-1939","authenticated-orcid":false,"given":"Roberto","family":"Cilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2024.106983_bib1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2024.106983_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106983_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson pandemic-A call to action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.106983_bib4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/mdc3.12294","article-title":"The accessibility of Parkinson's disease medication in Kenya: results of a national survey","volume":"3","author":"Mokaya","year":"2016","journal-title":"Mov. Disord. Clin. Pract"},{"issue":"10","key":"10.1016\/j.parkreldis.2024.106983_bib5","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/mds.28669","article-title":"Availability of therapies and services for Parkinson's disease in Africa: a continent-wide survey","volume":"36","author":"Hamid","year":"2021","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.106983_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/WNL.0000000000012198","article-title":"Quality improvement in neurology: 2020 Parkinson disease quality measurement set update","volume":"97","author":"Chou","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2024.106983_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2020.03.002","article-title":"Could Mucuna pruriens be the answer to Parkinson's disease management in sub-Saharan Africa and other low-income countries worldwide?","volume":"73","author":"Fothergill-Misbah","year":"2020","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.parkreldis.2024.106983_bib8","series-title":"Cover Crops in West Africa Contributing to Sustainable Agriculture","article-title":"The phytochemistry, toxicology, and food potential of velvet bean (Mucuna Adans. Spp., Fabaceae)","author":"Lorenzetti","year":"1998"},{"key":"10.1016\/j.parkreldis.2024.106983_bib9","article-title":"Agrobotanical, nutritional and bioactive potential of unconventional 370 legume - Mucuna","volume":"19","author":"Sridhar","year":"2007","journal-title":"Livest. Res. Rural Dev."},{"key":"10.1016\/j.parkreldis.2024.106983_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11130-005-8620-4","article-title":"Alternative food\/feed perspectives of an underutilized legume Mucuna pruriens var. Utilis\u2014a review","volume":"60","author":"Pugalenthi","year":"2005","journal-title":"Plant Foods Hum. Nutr."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.106983_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S2225-4110(16)30119-5","article-title":"The magic velvet bean of Mucuna pruriens","volume":"2","author":"Lampariello","year":"2012","journal-title":"J. Tradition. Complement. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106983_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02862271","article-title":"Velvetbean: a \u201cnew\u201d plant with a history","volume":"49","author":"Buckles","year":"1995","journal-title":"Econ. Bot."},{"key":"10.1016\/j.parkreldis.2024.106983_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jns.2016.04.001","article-title":"Mucuna pruriens for Parkinson's disease: low-cost preparation method, laboratory measures and pharmacokinetics profile","volume":"365","author":"Cassani","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106983_bib14","first-page":"69","article-title":"Phytochemistry and pharmacological activity of Mucuna pruriens: a review","volume":"11","author":"Yadav","year":"2017","journal-title":"Int. J. Green Pharm."},{"key":"10.1016\/j.parkreldis.2024.106983_bib15","series-title":"The Medicinal and Poisonous Legumes of India","first-page":"70","author":"Caius","year":"1989"},{"key":"10.1016\/j.parkreldis.2024.106983_bib16","volume":"ume 4","author":"Warrier","year":"1996"},{"key":"10.1016\/j.parkreldis.2024.106983_bib17","series-title":"Perspectives on New Crops and New Uses","first-page":"196","article-title":"Legume genetic resources with novel \"value added\" industrial and pharmaceutical use","author":"Morris","year":"1999"},{"key":"10.1016\/j.parkreldis.2024.106983_bib18","first-page":"295","article-title":"Indolealkylamines in Mucuna species","volume":"1","author":"Szabo","year":"2003","journal-title":"Tropical Subtrop. Agroecosyst."},{"issue":"3167","key":"10.1016\/j.parkreldis.2024.106983_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.122.3167.469","article-title":"The active pruritogenic proteinase of cowhage","volume":"122","author":"Shelley","year":"1955","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.parkreldis.2024.106983_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1055\/s-0028-1099642","article-title":"Alkaloids of Mucuna pruriens: chemistry and pharmacology","volume":"19","author":"Ghosal","year":"1971","journal-title":"Planta Med."},{"key":"10.1016\/j.parkreldis.2024.106983_bib21","series-title":"Production Technology of Medicinal and Aromatic Crops","author":"Farooqi","year":"1999"},{"key":"10.1016\/j.parkreldis.2024.106983_bib22","first-page":"92","article-title":"Indian medicinal plants V - Mucuna pruriens bark (Papilionaceae)","volume":"6","author":"Mehta","year":"1994","journal-title":"Indian J. Pharmacol."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.106983_bib23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/ajcn\/65.5.1489","article-title":"Antioxidant flavonols and ischaemic heart disease in a Welsh population of men - the caerphilly study","volume":"65","author":"Hertog","year":"1997","journal-title":"Am. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.parkreldis.2024.106983_bib24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0891-5849(95)02227-9","article-title":"Structure antioxidant activity relationships of flavonoids and phenolic acids","volume":"20","author":"Rice-Evans","year":"1996","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.parkreldis.2024.106983_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jep.2018.02.006","article-title":"Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2\/STAT5A signaling","volume":"217","author":"Sinha","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.106983_bib26","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1021\/jf970975b","article-title":"High molecular weight plant polyphenolics (tannins) as biological antioxidants","volume":"46","author":"Hagerman","year":"1998","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.parkreldis.2024.106983_bib27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ptr.962","article-title":"Effect of the alcohol extract of the seeds of Mucuna pruriens on free radicals and oxidative stress in albino rats","volume":"16","author":"Tripathi","year":"2002","journal-title":"Phytother Res."},{"issue":"45","key":"10.1016\/j.parkreldis.2024.106983_bib28","doi-asserted-by":"crossref","first-page":"7472","DOI":"10.1523\/JNEUROSCI.1384-23.2023","article-title":"Beyond the 5-ht2a receptor: classic and nonclassic targets in psychedelic drug action","volume":"43","author":"Cameron","year":"2023","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.106983_bib29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/mds.25420","article-title":"The history of parkinsonism: descriptions in ancient Indian medical literature","volume":"28","author":"Ovallath","year":"2013","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106983_bib30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3233\/JPD-181500","article-title":"Mucuna pruriens combined with carbidopa in Parkinson's disease: a case report","volume":"9","author":"Radder","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2024.106983_bib31","article-title":"Delivery of allied health therapies to people with Parkinson's disease in Africa","volume":"16","author":"Cilia","year":"2023","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106983_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mdc3.12682","article-title":"A nationwide survey of Parkinson's disease medicines availability and affordability in Nigeria","volume":"6","author":"Okubadejo","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.106983_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/mdc3.12294","article-title":"The accessibility of Parkinson's disease medication in Kenya: results of a national survey","volume":"3","author":"Mokaya","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"11","key":"10.1016\/j.parkreldis.2024.106983_bib34","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/mds.21898","article-title":"The prevalence of Parkinson's disease in rural Tanzania","volume":"23","author":"Dotchin","year":"2008","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.parkreldis.2024.106983_bib35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1474-4422(19)30195-4","article-title":"Parkinson's disease in the western pacific region","volume":"18","author":"Lim","year":"2019","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.parkreldis.2024.106983_bib36","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/mds.21035","article-title":"Direct costs of managing Parkinson's disease in India: concerns in a developing country","volume":"21","author":"Ragothaman","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2024.106983_bib37","article-title":"Economic burden analysis of Parkinson's disease patients in China","volume":"7","author":"Yang","year":"2017","journal-title":"Parkinson's Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106983_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410220105","article-title":"Multicenter study of Parkinson mortality with early versus later dopa treatment","volume":"22","author":"Diamond","year":"1987","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106983_bib39","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s13205-020-02532-7","article-title":"Mucuna pruriens in Parkinson's and in some other diseases: recent advancement and future prospective","volume":"10","author":"Rai","year":"2020","journal-title":"3 Biotech"},{"issue":"3","key":"10.1016\/j.parkreldis.2024.106983_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/acm.1995.1.249","article-title":"An alternative medicine treatment for Parkinson's disease: results of a multicenter clinical trial","volume":"1","year":"1995","journal-title":"J. Alternative Compl. Med."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106983_bib41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-510X(00)00329-4","article-title":"Association of L-DOPA with recovery following Ayurveda medication in Parkinson's disease","volume":"176","author":"Nagashayana","year":"2000","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106983_bib42","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1136\/jnnp.2003.028761","article-title":"Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study","volume":"75","author":"Katzenschlager","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.106983_bib43","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1212\/WNL.0000000000004175","article-title":"Mucuna pruriens in Parkinson disease: a double-blind, randomized, controlled, crossover study","volume":"89","author":"Cilia","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2024.106983_bib44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.parkreldis.2018.01.014","article-title":"Daily intake of Mucuna pruriens in advanced Parkinson's disease: a 16-week, noninferiority, randomized, crossover, pilot study","volume":"49","author":"Cilia","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2024.106983_bib45","article-title":"Japanese Mucuna pruriens (hasshou beans) showed fast-acting and long-lasting effects in Parkinson's disease","volume":"11","author":"Sakata","year":"2024","journal-title":"Intern. Med."},{"issue":"7","key":"10.1016\/j.parkreldis.2024.106983_bib46","first-page":"1816","article-title":"Mucuna pruriens seeds in treatment of Parkinson's disease: pharmacological review","volume":"47","author":"Kasture","year":"2013","journal-title":"Orient. Pharm. Exp. Med."},{"issue":"8723","key":"10.1016\/j.parkreldis.2024.106983_bib47","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0140-6736(90)92603-F","article-title":"Outbreak of acute toxic psychosis attributed to Mucuna pruriens","volume":"336","author":"Infante","year":"1990","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.parkreldis.2024.106983_bib48","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1474-4422(02)00105-9","article-title":"Experiences of Parkinson's disease in India","volume":"1","author":"Behari","year":"2002","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106983_bib49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4314\/gjas.v31i1.1959","article-title":"Characterization and preliminary evaluation of some accessions of local germplasm of velvet bean (Mucuna pruriens Dc var utilis Wall) of Ghana","volume":"31","author":"Bennet-Lartey","year":"1998","journal-title":"Ghana J. Agric. Sci."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106983_bib50","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1128\/aem.55.2.531-532.1989","article-title":"Effect of temperature on aflatoxin production in Mucuna pruriens seeds","volume":"55","author":"Roy","year":"1989","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.parkreldis.2024.106983_bib51","unstructured":"http:\/\/www.agriculturesnetwork.org\/magazines\/global\/more-than-rice\/ediblecover-crops."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106983_bib52","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12883-023-03414-0","article-title":"Transforming Parkinson's care in Africa (TraPCAf): protocol for a multimethodology national institute for health and care research global health research group project","volume":"23","author":"Walker","year":"2023","journal-title":"BMC Neurol."},{"issue":"7844","key":"10.1016\/j.parkreldis.2024.106983_bib53","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(73)92729-3","article-title":"A year's comparison of treatment of patients with Parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone","volume":"2","author":"Marsden","year":"1973","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.parkreldis.2024.106983_bib54","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/mds.25364","article-title":"Stalevo reduction in dyskinesia evaluation in Parkinson's disease (STRIDE-PD) investigators. Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson's disease","volume":"28","author":"Warren Olanow","year":"2013","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106983_bib55","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1042\/bj0312149","article-title":"Isolation of l-3:4-dihydroxyphenylalanine from the seeds of Mucuna pruriens","volume":"31","author":"Damodaran","year":"1937","journal-title":"Biochem. J."},{"issue":"10","key":"10.1016\/j.parkreldis.2024.106983_bib56","first-page":"1085","article-title":"Levodopa content of Mucuna pruriens supplements in the NIH dietary supplement label database","volume":"79","author":"Cohen","year":"2022","journal-title":"Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106983_bib57","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/acm.2017.0054","article-title":"Analysis of levodopa content in commercial Mucuna pruriens products using high-performance liquid chromatography with fluorescence detection","volume":"24","author":"Soumyanath","year":"2018","journal-title":"J. Alternative Compl. Med."},{"issue":"11","key":"10.1016\/j.parkreldis.2024.106983_bib58","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.3390\/molecules28114264","article-title":"Development and validation of a new LC-MS\/MS bioanalytical method for the simultaneous determination of levodopa, levodopa methyl ester, and carbidopa in human plasma samples","volume":"28","author":"Molteni","year":"2023","journal-title":"Molecules"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024009957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024009957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T12:28:18Z","timestamp":1719836898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802024009957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":58,"alternative-id":["S1353802024009957"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106983","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucuna pruriens to treat Parkinson's disease in low-income countries: Recommendations and practical guidelines from the farmer to clinical trials. Paving the way for future use in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106983"}}